LifeVantage Corporation Expands International Operations in Canada

LifeVantage Corporation Expands International Operations in Canada

SALT LAKE CITY, June 4, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, has announced that it has expanded its direct selling
business into Canada.

Previously, LifeVantage has sold its products, Protandim®, the Nrf2
Synergizer® and TrueScience® Anti-Aging Cream on a limited basis to preferred
customers in Canada, but did not offer the opportunity for interested
customers to participate in the company's business opportunity. Effective June
5, however, the company will be accepting applications for independent
distributors in Canada and will begin paying commissions to qualified
independent distributors later during the month of June.

"For nearly two years, our distributors and preferred customers have
demonstrated a substantial demand for our products and business opportunity
inCanada," said LifeVantage President and Chief Executive Officer Douglas C.
Robinson. "We also realize that a large opportunity exists for network
marketing growth in the country.The World Federation of Direct Selling
Associations reported a market of approximately 700,000 distributors and sales
of $2.2 billion in 2011 in Canada.We believe an expansion into Canada is,
therefore, directly in-line with our commitment to increase operations in
countries that we believe represent long-term growth opportunities."

Mr. Robinson continued, "We will begin our Canadian expansion by continuing to
offer both Protandim® and TrueScience® to preferred customers and now
distributors in Canada, and expect to offer our new LifeVantage Canine Health
product in Canada in the future."

With this expansion into Canada, LifeVantage is now doing business in the
United States, Canada, Mexico, Japan, Hong Kong and Australia.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), a leader in Nrf2 science and the maker
of Protandim®, the Nrf2 Synergizer® patented dietary supplement, TrueScience®
Anti-Aging Cream and LifeVantage^® Canine Health, is a science based
nutraceutical company.LifeVantage is dedicated to visionary science that
looks to transform wellness and anti-aging internally and externally with
products that dramatically reduce oxidative stress at the cellular level. The
Company was founded in 2003 and is headquartered in Salt Lake City, UT.

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
Words and expressions reflecting optimism, satisfaction or disappointment with
current prospects, as well as words such as "believe," "hopes," "intends,"
"estimates," "expects," "projects," "plans," "anticipates," "look forward to"
and variations thereof, identify forward-looking statements, but their absence
does not mean that a statement is not forward-looking. Examples of
forward-looking statements include, but are not limited to, statements we make
regarding our future growth and success in Canada. Such forward-looking
statements are not guarantees of performance and the Company's actual results
could differ materially from those contained in such statements. These
forward-looking statements are based on the Company's current expectations and
beliefs concerning future events affecting the Company and involve known and
unknown risks and uncertainties that may cause the Company's actual results or
outcomes to be materially different from those anticipated and discussed
herein. These risks and uncertainties include, among others, the Company's
inability to successfully expand our operations in existing and other markets
and thereafter manage our growth; the Company's ability to strengthen its
business in Japan; the Company's reliance on third party suppliers and
manufacturers; the Company's ability to retain independent distributors or to
attract new independent distributors on an ongoing basis; the Company's
ability to expand its product offerings; violations of law or our procedures
by the Company's independent distributors; the potential for third-party and
governmental actions involving the Company's network marketing efforts; the
potential for product liability claims against the Company; the risk that
government regulators and regulations could adversely affect the Company's
business; future laws or regulations may hinder or prohibit the production or
sale of the Company's existing product and any future products; unfavorable
publicity could materially hurt the Company's business; the Company's ability
to access raw materials for its Products as it grows; risks associated with
foreign currency fluctuations; and the Company's ability to protect its
intellectual property rights and the value of its product. These and other
risk factors are discussed in greater detail in the Company's Annual Report on
Form 10-K and its Quarterly Report on Form 10-Q under the caption "Risk
Factors," and in other documents filed by the Company from time to time with
the Securities and Exchange Commission. The Company cautions investors not to
place undue reliance on the forward-looking statements contained in this
document. All forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company undertakes no
obligation to revise or update these forward-looking statements to reflect
events or circumstances after the date of this document, except as required by

CONTACT: Investor Relations Contact:
         Cindy England (801) 432-9036
         Director of Investor Relations
         John Mills (310) 954-1105
         Senior Managing Director, ICR, LLC

company logo
Press spacebar to pause and continue. Press esc to stop.